Press release
Major Growth Driver Identified in 2025 Ribose-Nucleic Acid (RNA)-Based Therapeutics Market: Increasing Prevalence Of Cancer On The RNA-Based Therapeutics Market
Ribose-Nucleic Acid (RNA)-Based Therapeutics Market
Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for therapeutics based on ribose-nucleic acid (RNA) has witnessed significant expansion in the past few years. The market, which stands at $15.79 billion in 2024, is set to grow to $17.26 billion by 2025 with a compound annual growth rate (CAGR) of 9.3%. Factors driving this historic growth include increased investments and funding, the discovery of RNA interference (RNAi), clinical triumphs with antisense oligonucleotides (ASOs), supportive regulatory structures, and alliances and partnerships.
Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size Forecast: What's the Projected Valuation by 2029?
Over the coming years, the market for ribose-nucleic acid (RNA)-based therapeutics is projected to experience robust growth. It is expected to expand to $24.26 billion by 2029, with a compound annual growth rate (CAGR) of 8.9%. Various factors contribute to this predicted market growth during the forecast period, such as expanding indications, growing market demand and adoption, regulatory support, the influx of AI and machine learning, and their emergent utilisation in rare diseases. Upcoming trends for this period include the development of superior delivery systems, RNA therapeutics aimed at multiple targets, personalised RNA therapies, advancements in regulation, and commercialisation which are fostering market growth.
View the full report here:
https://www.thebusinessresearchcompany.com/report/ribose-nucleic-acid-rna-based-therapeutics-global-market-report
What Are the Drivers Transforming the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The rising occurrence of cancer is anticipated to spur the evolution of the ribose-nucleic acid (RNA)-based therapeutics market in the future. Cancer is a disease where irregular cells proliferate and disperse unchecked, which could potentially result in death if not treated. This growing incidence of cancer is attributable to an aging demographic, alterations in lifestyle, increased exposure to hazards, and advancements in detection techniques. RNA-based therapeutics present a significant potential for treating cancer by directly addressing the cancer's genetic and molecular processes. For example, in August 2023, around 151,000 people were diagnosed with cancer, (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin) in 2021, as per data from the Australian Institute of Health and Welfare, a health-focused government agency in Australia. This figure is anticipated to rise to 185,000 by 2030. Consequently, the escalating incidence of cancer is fuelling the growth of the ribose-nucleic acid (RNA)-based therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
What Long-Term Trends Will Define the Future of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
Leading firms in the ribose nucleic acid (RNA)-based therapeutics market are putting their efforts into the creation of groundbreaking medical solutions like messenger RNA (mRNA)-based booster vaccines, with the aim of boosting immunization efficiency, tackling new viral strains, and augmenting the overall longevity of vaccine-induced immunity. The mechanism of an mRNA-based booster vaccine involves using messenger RNA to instigate cells to produce a protein that intensifies the body's immune defense against a specific pathogen. For example, Gennova Biopharmaceuticals Ltd., an India-based pharmaceutical firm, in June 2023, rolled out GEMCOVAC-OM, the first mRNA booster vaccine developed in India specifically for combating the Omicron variant of COVID-19. This booster becomes crucial due to the restricted effectiveness of the initial vaccines against Omicron. Leaning on mRNA technology, GEMCOVAC-OM bolsters immunity and provides superior protection against the mutating virus.
Which Segments in the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Offer the Most Profit Potential?
The ribose-nucleic acid (RNA)-based therapeutics market covered in this report is segmented -
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18454&type=smp
Which Firms Dominate the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market by Market Share and Revenue in 2025?
Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics
Which Regions Offer the Highest Growth Potential in the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18454
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major Growth Driver Identified in 2025 Ribose-Nucleic Acid (RNA)-Based Therapeutics Market: Increasing Prevalence Of Cancer On The RNA-Based Therapeutics Market here
News-ID: 4139304 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for RNA
Small Interfering RNA (siRNA) Therapeutics Market Growth (2026-2033) | RNA Drugs …
DataM Intelligence has released a new research report titled "Small Interfering RNA (siRNA) Therapeutics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market…
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
